Drug resistance, antibiotics, superbugs, supply chain, pig farming

SUPPORT OUR SITE
7/13/18

Superbugs

Enable IntenseDebate Comments: 
Enable IntenseDebate Comments

Antibiotic development efforts were dealt a blow Wednesday when drug maker Novartis AG announced its decision to drop its antibacterial and antiviral research programs.

The decision means Novartis will no longer be working on several antimicrobial projects currently in development.

read more


VISIT THE SOURCE ARTICLE

Drug resistance, antibiotics, superbugs, supply chain, pig farming

Author: administrator